Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene
- PMID: 10455061
- DOI: 10.1161/01.res.85.4.329
Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene
Abstract
Heart-type fatty acid binding protein (H-FABP), abundantly expressed in cardiac myocytes, has been postulated to facilitate the cardiac uptake of long-chain fatty acids (LCFAs) and to promote their intracellular trafficking to sites of metabolic conversion. Mice with a disrupted H-FABP gene were recently shown to have elevated plasma LCFA levels, decreased cardiac deposition of a LCFA analogue, and increased cardiac deoxyglucose uptake, which qualitatively establishes a requirement for H-FABP in cardiac LCFA utilization. To study the underlying defect, we developed a method to isolate intact, electrically stimulatable cardiac myocytes from adult mice and then studied substrate utilization under defined conditions in quiescent and in contracting cells from wild-type and H-FABP(-/-) mice. Our results demonstrate that in resting and in contracting myocytes from H-FABP(-/-) mice, both uptake and oxidation of palmitate are markedly reduced (between -45% and -65%), whereas cellular octanoate uptake, and the capacities of heart homogenates for palmitate oxidation and for octanoate oxidation, and the cardiac levels of mRNAs encoding sarcolemmal FA transporters remain unaltered. In contrast, in resting H-FABP(-/-) cardiac myocytes, glucose oxidation is increased (+80%) to a level that would require electrical stimulation in wild-type cells. These findings provide a physiological demonstration of a crucial role of H-FABP in uptake and oxidation of LCFAs in cardiac muscle cells and indicate that in H-FABP(-/-) mice the diminished contribution of LCFAs to cardiac energy production is, at least in part, compensated for by an increase in glucose oxidation.
Similar articles
-
Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice.Lipids. 2003 Apr;38(4):491-6. doi: 10.1007/s11745-003-1089-6. Lipids. 2003. PMID: 12848299
-
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization.FASEB J. 1999 May;13(8):805-12. doi: 10.1096/fasebj.13.8.805. FASEB J. 1999. PMID: 10224224
-
A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism.Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E481-9. doi: 10.1152/ajpendo.00060.2003. Am J Physiol Endocrinol Metab. 2003. PMID: 12900378
-
Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle.Acta Physiol Scand. 2003 Aug;178(4):367-71. doi: 10.1046/j.1365-201X.2003.01166.x. Acta Physiol Scand. 2003. PMID: 12864741 Review.
-
Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes.Prostaglandins Leukot Essent Fatty Acids. 1997 Jul;57(1):39-45. doi: 10.1016/s0952-3278(97)90491-9. Prostaglandins Leukot Essent Fatty Acids. 1997. PMID: 9250607 Review.
Cited by
-
Tissue-specific functions in the fatty acid-binding protein family.J Biol Chem. 2010 Oct 22;285(43):32679-32683. doi: 10.1074/jbc.R110.135210. Epub 2010 Aug 17. J Biol Chem. 2010. PMID: 20716527 Free PMC article. Review.
-
Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice.Lipids. 2003 Apr;38(4):491-6. doi: 10.1007/s11745-003-1089-6. Lipids. 2003. PMID: 12848299
-
Protein-mediated Fatty Acid Uptake in the Heart.Curr Cardiol Rev. 2008 Feb;4(1):12-21. doi: 10.2174/157340308783565429. Curr Cardiol Rev. 2008. PMID: 19924273 Free PMC article.
-
Down-regulation of heart HFABP and UCP2 gene expression in diet-induced (cafeteria) obese rats.J Physiol Biochem. 2002 Jun;58(2):69-74. doi: 10.1007/BF03179841. J Physiol Biochem. 2002. PMID: 12435081
-
Heart and liver fatty acid binding proteins and the metabolic syndrome.Curr Hypertens Rep. 2005 Dec;7(6):401-6. doi: 10.1007/s11906-005-0033-0. Curr Hypertens Rep. 2005. PMID: 16386194 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases